Computational drug discovery and design embodies the integration of advanced computational methods, machine learning, and cheminformatics to streamline the identification and optimisation of ...

Drug discovery is a costly and time-intensive process, with binding free energy calculations between the potential drug molecule and the target being crucial for reducing drug discovery costs, ...

Hitting targets embedded within the cell membrane has long been difficult for drug developers due to the membrane's challenging biochemical properties. Now, chemists have demonstrated new ...

A close-up shot of two scientists’ hands in a lab. PsiThera intends to make drugs for immunological and inflammatory conditions. Credit: Shutterstock A new start-up called PsiThera has spun out of ...

A two-day workshop in Mysuru on modern drug design gathered 62 delegates to explore advanced strategies in pharmaceutical research.

Optibrium, a leading developer of software and AI solutions for drug discovery, today announced the acquisition of BioPharmics LLC, expanding its 3D drug design and modelling offering. Bringing ...

Discover how Optibrium is transforming early-stage drug discovery through AI-powered software, generative chemistry, and 3D modelling. In this interview, Matt Segall, CEO at Optibrium, shares insights ...

At NVIDIA's GTC 2025 event in San Jose, California, this week – the so-called "Super Bowl of AI" – the chip giant announced multiple partnerships leveraging the power of AI to turbocharge applications ...

Survival Outcomes of Patients With Tropomyosin Receptor Kinase Fusion-Positive Cancer Receiving Larotrectinib Versus Standard of Care: A Matching-Adjusted Indirect Comparison Using Real-World Data ...

Computational drug discovery and design integrates advanced computer‐aided methodologies with chemical and biological insights to accelerate the identification and optimisation of therapeutic agents.